Global Universal Cell Therapy Drug Supply, Demand and Key Producers, 2023-2029
The global Universal Cell Therapy Drug market size is expected to reach $ 1048.9 million by 2029, rising at a market growth of 16.1% CAGR during the forecast period (2023-2029).
Universal cell therapies are a revolutionary class of medicines that use biotechnology to modify a patient's cells to treat a variety of diseases, including cancer, genetic disorders and autoimmune diseases. Increasingly, generic cell therapies will move toward personalized treatments to tailor treatment plans to each patient's specific condition and genotype. Universal cell therapies continue to expand their indications to include the treatment of rare diseases, autoimmune diseases and other diseases. Universal cell therapy drugs represent an important innovation in medicine, providing new treatment options for patients with serious diseases. With the continuous development of technology and the accumulation of clinical practice, universal cell therapy will continue to play an important role in the medical field.
This report studies the global Universal Cell Therapy Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Universal Cell Therapy Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Universal Cell Therapy Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Universal Cell Therapy Drug total production and demand, 2018-2029, (K Units)
Global Universal Cell Therapy Drug total production value, 2018-2029, (USD Million)
Global Universal Cell Therapy Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Universal Cell Therapy Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Universal Cell Therapy Drug domestic production, consumption, key domestic manufacturers and share
Global Universal Cell Therapy Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Universal Cell Therapy Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Universal Cell Therapy Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Universal Cell Therapy Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bluebird Bio, Juno Therapeutics, Spark Therapeutics, Kite Pharma, Celgene, Regeneron Pharmaceuticals and Adaptimmune, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Universal Cell Therapy Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Universal Cell Therapy Drug Market, By Region:
1. How big is the global Universal Cell Therapy Drug market?
2. What is the demand of the global Universal Cell Therapy Drug market?
3. What is the year over year growth of the global Universal Cell Therapy Drug market?
4. What is the production and production value of the global Universal Cell Therapy Drug market?
5. Who are the key producers in the global Universal Cell Therapy Drug market?
Universal cell therapies are a revolutionary class of medicines that use biotechnology to modify a patient's cells to treat a variety of diseases, including cancer, genetic disorders and autoimmune diseases. Increasingly, generic cell therapies will move toward personalized treatments to tailor treatment plans to each patient's specific condition and genotype. Universal cell therapies continue to expand their indications to include the treatment of rare diseases, autoimmune diseases and other diseases. Universal cell therapy drugs represent an important innovation in medicine, providing new treatment options for patients with serious diseases. With the continuous development of technology and the accumulation of clinical practice, universal cell therapy will continue to play an important role in the medical field.
This report studies the global Universal Cell Therapy Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Universal Cell Therapy Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Universal Cell Therapy Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Universal Cell Therapy Drug total production and demand, 2018-2029, (K Units)
Global Universal Cell Therapy Drug total production value, 2018-2029, (USD Million)
Global Universal Cell Therapy Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Universal Cell Therapy Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Universal Cell Therapy Drug domestic production, consumption, key domestic manufacturers and share
Global Universal Cell Therapy Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Universal Cell Therapy Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Universal Cell Therapy Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Universal Cell Therapy Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bluebird Bio, Juno Therapeutics, Spark Therapeutics, Kite Pharma, Celgene, Regeneron Pharmaceuticals and Adaptimmune, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Universal Cell Therapy Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Universal Cell Therapy Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Cell Therapy
- Gene Therapy
- Stem Cell Therapy
- Hospital
- Research Center
- Novartis
- Gilead Sciences
- Bluebird Bio
- Juno Therapeutics
- Spark Therapeutics
- Kite Pharma
- Celgene
- Regeneron Pharmaceuticals
- Adaptimmune
- CRISPR Therapeutics
1. How big is the global Universal Cell Therapy Drug market?
2. What is the demand of the global Universal Cell Therapy Drug market?
3. What is the year over year growth of the global Universal Cell Therapy Drug market?
4. What is the production and production value of the global Universal Cell Therapy Drug market?
5. Who are the key producers in the global Universal Cell Therapy Drug market?
1 SUPPLY SUMMARY
1.1 Universal Cell Therapy Drug Introduction
1.2 World Universal Cell Therapy Drug Supply & Forecast
1.2.1 World Universal Cell Therapy Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Universal Cell Therapy Drug Production (2018-2029)
1.2.3 World Universal Cell Therapy Drug Pricing Trends (2018-2029)
1.3 World Universal Cell Therapy Drug Production by Region (Based on Production Site)
1.3.1 World Universal Cell Therapy Drug Production Value by Region (2018-2029)
1.3.2 World Universal Cell Therapy Drug Production by Region (2018-2029)
1.3.3 World Universal Cell Therapy Drug Average Price by Region (2018-2029)
1.3.4 North America Universal Cell Therapy Drug Production (2018-2029)
1.3.5 Europe Universal Cell Therapy Drug Production (2018-2029)
1.3.6 China Universal Cell Therapy Drug Production (2018-2029)
1.3.7 Japan Universal Cell Therapy Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Universal Cell Therapy Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Universal Cell Therapy Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Universal Cell Therapy Drug Demand (2018-2029)
2.2 World Universal Cell Therapy Drug Consumption by Region
2.2.1 World Universal Cell Therapy Drug Consumption by Region (2018-2023)
2.2.2 World Universal Cell Therapy Drug Consumption Forecast by Region (2024-2029)
2.3 United States Universal Cell Therapy Drug Consumption (2018-2029)
2.4 China Universal Cell Therapy Drug Consumption (2018-2029)
2.5 Europe Universal Cell Therapy Drug Consumption (2018-2029)
2.6 Japan Universal Cell Therapy Drug Consumption (2018-2029)
2.7 South Korea Universal Cell Therapy Drug Consumption (2018-2029)
2.8 ASEAN Universal Cell Therapy Drug Consumption (2018-2029)
2.9 India Universal Cell Therapy Drug Consumption (2018-2029)
3 WORLD UNIVERSAL CELL THERAPY DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Universal Cell Therapy Drug Production Value by Manufacturer (2018-2023)
3.2 World Universal Cell Therapy Drug Production by Manufacturer (2018-2023)
3.3 World Universal Cell Therapy Drug Average Price by Manufacturer (2018-2023)
3.4 Universal Cell Therapy Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Universal Cell Therapy Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Universal Cell Therapy Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Universal Cell Therapy Drug in 2022
3.6 Universal Cell Therapy Drug Market: Overall Company Footprint Analysis
3.6.1 Universal Cell Therapy Drug Market: Region Footprint
3.6.2 Universal Cell Therapy Drug Market: Company Product Type Footprint
3.6.3 Universal Cell Therapy Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Universal Cell Therapy Drug Production Value Comparison
4.1.1 United States VS China: Universal Cell Therapy Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Universal Cell Therapy Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Universal Cell Therapy Drug Production Comparison
4.2.1 United States VS China: Universal Cell Therapy Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Universal Cell Therapy Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Universal Cell Therapy Drug Consumption Comparison
4.3.1 United States VS China: Universal Cell Therapy Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Universal Cell Therapy Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Universal Cell Therapy Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Universal Cell Therapy Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Universal Cell Therapy Drug Production (2018-2023)
4.5 China Based Universal Cell Therapy Drug Manufacturers and Market Share
4.5.1 China Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Universal Cell Therapy Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Universal Cell Therapy Drug Production (2018-2023)
4.6 Rest of World Based Universal Cell Therapy Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Universal Cell Therapy Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Universal Cell Therapy Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Universal Cell Therapy Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cell Therapy
5.2.2 Gene Therapy
5.2.3 Stem Cell Therapy
5.3 Market Segment by Type
5.3.1 World Universal Cell Therapy Drug Production by Type (2018-2029)
5.3.2 World Universal Cell Therapy Drug Production Value by Type (2018-2029)
5.3.3 World Universal Cell Therapy Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Universal Cell Therapy Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Research Center
6.3 Market Segment by Application
6.3.1 World Universal Cell Therapy Drug Production by Application (2018-2029)
6.3.2 World Universal Cell Therapy Drug Production Value by Application (2018-2029)
6.3.3 World Universal Cell Therapy Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Universal Cell Therapy Drug Product and Services
7.1.4 Novartis Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Gilead Sciences
7.2.1 Gilead Sciences Details
7.2.2 Gilead Sciences Major Business
7.2.3 Gilead Sciences Universal Cell Therapy Drug Product and Services
7.2.4 Gilead Sciences Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Gilead Sciences Recent Developments/Updates
7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
7.3 Bluebird Bio
7.3.1 Bluebird Bio Details
7.3.2 Bluebird Bio Major Business
7.3.3 Bluebird Bio Universal Cell Therapy Drug Product and Services
7.3.4 Bluebird Bio Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bluebird Bio Recent Developments/Updates
7.3.6 Bluebird Bio Competitive Strengths & Weaknesses
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Details
7.4.2 Juno Therapeutics Major Business
7.4.3 Juno Therapeutics Universal Cell Therapy Drug Product and Services
7.4.4 Juno Therapeutics Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Juno Therapeutics Recent Developments/Updates
7.4.6 Juno Therapeutics Competitive Strengths & Weaknesses
7.5 Spark Therapeutics
7.5.1 Spark Therapeutics Details
7.5.2 Spark Therapeutics Major Business
7.5.3 Spark Therapeutics Universal Cell Therapy Drug Product and Services
7.5.4 Spark Therapeutics Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Spark Therapeutics Recent Developments/Updates
7.5.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.6 Kite Pharma
7.6.1 Kite Pharma Details
7.6.2 Kite Pharma Major Business
7.6.3 Kite Pharma Universal Cell Therapy Drug Product and Services
7.6.4 Kite Pharma Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Kite Pharma Recent Developments/Updates
7.6.6 Kite Pharma Competitive Strengths & Weaknesses
7.7 Celgene
7.7.1 Celgene Details
7.7.2 Celgene Major Business
7.7.3 Celgene Universal Cell Therapy Drug Product and Services
7.7.4 Celgene Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Celgene Recent Developments/Updates
7.7.6 Celgene Competitive Strengths & Weaknesses
7.8 Regeneron Pharmaceuticals
7.8.1 Regeneron Pharmaceuticals Details
7.8.2 Regeneron Pharmaceuticals Major Business
7.8.3 Regeneron Pharmaceuticals Universal Cell Therapy Drug Product and Services
7.8.4 Regeneron Pharmaceuticals Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Regeneron Pharmaceuticals Recent Developments/Updates
7.8.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Adaptimmune
7.9.1 Adaptimmune Details
7.9.2 Adaptimmune Major Business
7.9.3 Adaptimmune Universal Cell Therapy Drug Product and Services
7.9.4 Adaptimmune Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Adaptimmune Recent Developments/Updates
7.9.6 Adaptimmune Competitive Strengths & Weaknesses
7.10 CRISPR Therapeutics
7.10.1 CRISPR Therapeutics Details
7.10.2 CRISPR Therapeutics Major Business
7.10.3 CRISPR Therapeutics Universal Cell Therapy Drug Product and Services
7.10.4 CRISPR Therapeutics Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 CRISPR Therapeutics Recent Developments/Updates
7.10.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Universal Cell Therapy Drug Industry Chain
8.2 Universal Cell Therapy Drug Upstream Analysis
8.2.1 Universal Cell Therapy Drug Core Raw Materials
8.2.2 Main Manufacturers of Universal Cell Therapy Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Universal Cell Therapy Drug Production Mode
8.6 Universal Cell Therapy Drug Procurement Model
8.7 Universal Cell Therapy Drug Industry Sales Model and Sales Channels
8.7.1 Universal Cell Therapy Drug Sales Model
8.7.2 Universal Cell Therapy Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Universal Cell Therapy Drug Introduction
1.2 World Universal Cell Therapy Drug Supply & Forecast
1.2.1 World Universal Cell Therapy Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Universal Cell Therapy Drug Production (2018-2029)
1.2.3 World Universal Cell Therapy Drug Pricing Trends (2018-2029)
1.3 World Universal Cell Therapy Drug Production by Region (Based on Production Site)
1.3.1 World Universal Cell Therapy Drug Production Value by Region (2018-2029)
1.3.2 World Universal Cell Therapy Drug Production by Region (2018-2029)
1.3.3 World Universal Cell Therapy Drug Average Price by Region (2018-2029)
1.3.4 North America Universal Cell Therapy Drug Production (2018-2029)
1.3.5 Europe Universal Cell Therapy Drug Production (2018-2029)
1.3.6 China Universal Cell Therapy Drug Production (2018-2029)
1.3.7 Japan Universal Cell Therapy Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Universal Cell Therapy Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Universal Cell Therapy Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Universal Cell Therapy Drug Demand (2018-2029)
2.2 World Universal Cell Therapy Drug Consumption by Region
2.2.1 World Universal Cell Therapy Drug Consumption by Region (2018-2023)
2.2.2 World Universal Cell Therapy Drug Consumption Forecast by Region (2024-2029)
2.3 United States Universal Cell Therapy Drug Consumption (2018-2029)
2.4 China Universal Cell Therapy Drug Consumption (2018-2029)
2.5 Europe Universal Cell Therapy Drug Consumption (2018-2029)
2.6 Japan Universal Cell Therapy Drug Consumption (2018-2029)
2.7 South Korea Universal Cell Therapy Drug Consumption (2018-2029)
2.8 ASEAN Universal Cell Therapy Drug Consumption (2018-2029)
2.9 India Universal Cell Therapy Drug Consumption (2018-2029)
3 WORLD UNIVERSAL CELL THERAPY DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Universal Cell Therapy Drug Production Value by Manufacturer (2018-2023)
3.2 World Universal Cell Therapy Drug Production by Manufacturer (2018-2023)
3.3 World Universal Cell Therapy Drug Average Price by Manufacturer (2018-2023)
3.4 Universal Cell Therapy Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Universal Cell Therapy Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Universal Cell Therapy Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Universal Cell Therapy Drug in 2022
3.6 Universal Cell Therapy Drug Market: Overall Company Footprint Analysis
3.6.1 Universal Cell Therapy Drug Market: Region Footprint
3.6.2 Universal Cell Therapy Drug Market: Company Product Type Footprint
3.6.3 Universal Cell Therapy Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Universal Cell Therapy Drug Production Value Comparison
4.1.1 United States VS China: Universal Cell Therapy Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Universal Cell Therapy Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Universal Cell Therapy Drug Production Comparison
4.2.1 United States VS China: Universal Cell Therapy Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Universal Cell Therapy Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Universal Cell Therapy Drug Consumption Comparison
4.3.1 United States VS China: Universal Cell Therapy Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Universal Cell Therapy Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Universal Cell Therapy Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Universal Cell Therapy Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Universal Cell Therapy Drug Production (2018-2023)
4.5 China Based Universal Cell Therapy Drug Manufacturers and Market Share
4.5.1 China Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Universal Cell Therapy Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Universal Cell Therapy Drug Production (2018-2023)
4.6 Rest of World Based Universal Cell Therapy Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Universal Cell Therapy Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Universal Cell Therapy Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Universal Cell Therapy Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Cell Therapy
5.2.2 Gene Therapy
5.2.3 Stem Cell Therapy
5.3 Market Segment by Type
5.3.1 World Universal Cell Therapy Drug Production by Type (2018-2029)
5.3.2 World Universal Cell Therapy Drug Production Value by Type (2018-2029)
5.3.3 World Universal Cell Therapy Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Universal Cell Therapy Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Research Center
6.3 Market Segment by Application
6.3.1 World Universal Cell Therapy Drug Production by Application (2018-2029)
6.3.2 World Universal Cell Therapy Drug Production Value by Application (2018-2029)
6.3.3 World Universal Cell Therapy Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Novartis
7.1.1 Novartis Details
7.1.2 Novartis Major Business
7.1.3 Novartis Universal Cell Therapy Drug Product and Services
7.1.4 Novartis Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Novartis Recent Developments/Updates
7.1.6 Novartis Competitive Strengths & Weaknesses
7.2 Gilead Sciences
7.2.1 Gilead Sciences Details
7.2.2 Gilead Sciences Major Business
7.2.3 Gilead Sciences Universal Cell Therapy Drug Product and Services
7.2.4 Gilead Sciences Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Gilead Sciences Recent Developments/Updates
7.2.6 Gilead Sciences Competitive Strengths & Weaknesses
7.3 Bluebird Bio
7.3.1 Bluebird Bio Details
7.3.2 Bluebird Bio Major Business
7.3.3 Bluebird Bio Universal Cell Therapy Drug Product and Services
7.3.4 Bluebird Bio Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bluebird Bio Recent Developments/Updates
7.3.6 Bluebird Bio Competitive Strengths & Weaknesses
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Details
7.4.2 Juno Therapeutics Major Business
7.4.3 Juno Therapeutics Universal Cell Therapy Drug Product and Services
7.4.4 Juno Therapeutics Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Juno Therapeutics Recent Developments/Updates
7.4.6 Juno Therapeutics Competitive Strengths & Weaknesses
7.5 Spark Therapeutics
7.5.1 Spark Therapeutics Details
7.5.2 Spark Therapeutics Major Business
7.5.3 Spark Therapeutics Universal Cell Therapy Drug Product and Services
7.5.4 Spark Therapeutics Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Spark Therapeutics Recent Developments/Updates
7.5.6 Spark Therapeutics Competitive Strengths & Weaknesses
7.6 Kite Pharma
7.6.1 Kite Pharma Details
7.6.2 Kite Pharma Major Business
7.6.3 Kite Pharma Universal Cell Therapy Drug Product and Services
7.6.4 Kite Pharma Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Kite Pharma Recent Developments/Updates
7.6.6 Kite Pharma Competitive Strengths & Weaknesses
7.7 Celgene
7.7.1 Celgene Details
7.7.2 Celgene Major Business
7.7.3 Celgene Universal Cell Therapy Drug Product and Services
7.7.4 Celgene Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Celgene Recent Developments/Updates
7.7.6 Celgene Competitive Strengths & Weaknesses
7.8 Regeneron Pharmaceuticals
7.8.1 Regeneron Pharmaceuticals Details
7.8.2 Regeneron Pharmaceuticals Major Business
7.8.3 Regeneron Pharmaceuticals Universal Cell Therapy Drug Product and Services
7.8.4 Regeneron Pharmaceuticals Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Regeneron Pharmaceuticals Recent Developments/Updates
7.8.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Adaptimmune
7.9.1 Adaptimmune Details
7.9.2 Adaptimmune Major Business
7.9.3 Adaptimmune Universal Cell Therapy Drug Product and Services
7.9.4 Adaptimmune Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Adaptimmune Recent Developments/Updates
7.9.6 Adaptimmune Competitive Strengths & Weaknesses
7.10 CRISPR Therapeutics
7.10.1 CRISPR Therapeutics Details
7.10.2 CRISPR Therapeutics Major Business
7.10.3 CRISPR Therapeutics Universal Cell Therapy Drug Product and Services
7.10.4 CRISPR Therapeutics Universal Cell Therapy Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 CRISPR Therapeutics Recent Developments/Updates
7.10.6 CRISPR Therapeutics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Universal Cell Therapy Drug Industry Chain
8.2 Universal Cell Therapy Drug Upstream Analysis
8.2.1 Universal Cell Therapy Drug Core Raw Materials
8.2.2 Main Manufacturers of Universal Cell Therapy Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Universal Cell Therapy Drug Production Mode
8.6 Universal Cell Therapy Drug Procurement Model
8.7 Universal Cell Therapy Drug Industry Sales Model and Sales Channels
8.7.1 Universal Cell Therapy Drug Sales Model
8.7.2 Universal Cell Therapy Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Universal Cell Therapy Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Universal Cell Therapy Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Universal Cell Therapy Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Universal Cell Therapy Drug Production Value Market Share by Region (2018-2023)
Table 5. World Universal Cell Therapy Drug Production Value Market Share by Region (2024-2029)
Table 6. World Universal Cell Therapy Drug Production by Region (2018-2023) & (K Units)
Table 7. World Universal Cell Therapy Drug Production by Region (2024-2029) & (K Units)
Table 8. World Universal Cell Therapy Drug Production Market Share by Region (2018-2023)
Table 9. World Universal Cell Therapy Drug Production Market Share by Region (2024-2029)
Table 10. World Universal Cell Therapy Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Universal Cell Therapy Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Universal Cell Therapy Drug Major Market Trends
Table 13. World Universal Cell Therapy Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Universal Cell Therapy Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Universal Cell Therapy Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Universal Cell Therapy Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Universal Cell Therapy Drug Producers in 2022
Table 18. World Universal Cell Therapy Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Universal Cell Therapy Drug Producers in 2022
Table 20. World Universal Cell Therapy Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Universal Cell Therapy Drug Company Evaluation Quadrant
Table 22. World Universal Cell Therapy Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Universal Cell Therapy Drug Production Site of Key Manufacturer
Table 24. Universal Cell Therapy Drug Market: Company Product Type Footprint
Table 25. Universal Cell Therapy Drug Market: Company Product Application Footprint
Table 26. Universal Cell Therapy Drug Competitive Factors
Table 27. Universal Cell Therapy Drug New Entrant and Capacity Expansion Plans
Table 28. Universal Cell Therapy Drug Mergers & Acquisitions Activity
Table 29. United States VS China Universal Cell Therapy Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Universal Cell Therapy Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Universal Cell Therapy Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Universal Cell Therapy Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Universal Cell Therapy Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Universal Cell Therapy Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Universal Cell Therapy Drug Production Market Share (2018-2023)
Table 37. China Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Universal Cell Therapy Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Universal Cell Therapy Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Universal Cell Therapy Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Universal Cell Therapy Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Universal Cell Therapy Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Universal Cell Therapy Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Universal Cell Therapy Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Universal Cell Therapy Drug Production Market Share (2018-2023)
Table 47. World Universal Cell Therapy Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Universal Cell Therapy Drug Production by Type (2018-2023) & (K Units)
Table 49. World Universal Cell Therapy Drug Production by Type (2024-2029) & (K Units)
Table 50. World Universal Cell Therapy Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Universal Cell Therapy Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Universal Cell Therapy Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Universal Cell Therapy Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Universal Cell Therapy Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Universal Cell Therapy Drug Production by Application (2018-2023) & (K Units)
Table 56. World Universal Cell Therapy Drug Production by Application (2024-2029) & (K Units)
Table 57. World Universal Cell Therapy Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Universal Cell Therapy Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Universal Cell Therapy Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Universal Cell Therapy Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Universal Cell Therapy Drug Product and Services
Table 64. Novartis Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 68. Gilead Sciences Major Business
Table 69. Gilead Sciences Universal Cell Therapy Drug Product and Services
Table 70. Gilead Sciences Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Gilead Sciences Recent Developments/Updates
Table 72. Gilead Sciences Competitive Strengths & Weaknesses
Table 73. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 74. Bluebird Bio Major Business
Table 75. Bluebird Bio Universal Cell Therapy Drug Product and Services
Table 76. Bluebird Bio Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bluebird Bio Recent Developments/Updates
Table 78. Bluebird Bio Competitive Strengths & Weaknesses
Table 79. Juno Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. Juno Therapeutics Major Business
Table 81. Juno Therapeutics Universal Cell Therapy Drug Product and Services
Table 82. Juno Therapeutics Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Juno Therapeutics Recent Developments/Updates
Table 84. Juno Therapeutics Competitive Strengths & Weaknesses
Table 85. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Spark Therapeutics Major Business
Table 87. Spark Therapeutics Universal Cell Therapy Drug Product and Services
Table 88. Spark Therapeutics Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Spark Therapeutics Recent Developments/Updates
Table 90. Spark Therapeutics Competitive Strengths & Weaknesses
Table 91. Kite Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Kite Pharma Major Business
Table 93. Kite Pharma Universal Cell Therapy Drug Product and Services
Table 94. Kite Pharma Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Kite Pharma Recent Developments/Updates
Table 96. Kite Pharma Competitive Strengths & Weaknesses
Table 97. Celgene Basic Information, Manufacturing Base and Competitors
Table 98. Celgene Major Business
Table 99. Celgene Universal Cell Therapy Drug Product and Services
Table 100. Celgene Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Celgene Recent Developments/Updates
Table 102. Celgene Competitive Strengths & Weaknesses
Table 103. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Regeneron Pharmaceuticals Major Business
Table 105. Regeneron Pharmaceuticals Universal Cell Therapy Drug Product and Services
Table 106. Regeneron Pharmaceuticals Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Regeneron Pharmaceuticals Recent Developments/Updates
Table 108. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Adaptimmune Basic Information, Manufacturing Base and Competitors
Table 110. Adaptimmune Major Business
Table 111. Adaptimmune Universal Cell Therapy Drug Product and Services
Table 112. Adaptimmune Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Adaptimmune Recent Developments/Updates
Table 114. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 115. CRISPR Therapeutics Major Business
Table 116. CRISPR Therapeutics Universal Cell Therapy Drug Product and Services
Table 117. CRISPR Therapeutics Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Universal Cell Therapy Drug Upstream (Raw Materials)
Table 119. Universal Cell Therapy Drug Typical Customers
Table 120. Universal Cell Therapy Drug Typical Distributors
LIST OF FIGURE
Figure 1. Universal Cell Therapy Drug Picture
Figure 2. World Universal Cell Therapy Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Universal Cell Therapy Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Universal Cell Therapy Drug Production (2018-2029) & (K Units)
Figure 5. World Universal Cell Therapy Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Universal Cell Therapy Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Universal Cell Therapy Drug Production Market Share by Region (2018-2029)
Figure 8. North America Universal Cell Therapy Drug Production (2018-2029) & (K Units)
Figure 9. Europe Universal Cell Therapy Drug Production (2018-2029) & (K Units)
Figure 10. China Universal Cell Therapy Drug Production (2018-2029) & (K Units)
Figure 11. Japan Universal Cell Therapy Drug Production (2018-2029) & (K Units)
Figure 12. Universal Cell Therapy Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 15. World Universal Cell Therapy Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 17. China Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 22. India Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Universal Cell Therapy Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Universal Cell Therapy Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Universal Cell Therapy Drug Markets in 2022
Figure 26. United States VS China: Universal Cell Therapy Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Universal Cell Therapy Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Universal Cell Therapy Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Universal Cell Therapy Drug Production Market Share 2022
Figure 30. China Based Manufacturers Universal Cell Therapy Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Universal Cell Therapy Drug Production Market Share 2022
Figure 32. World Universal Cell Therapy Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Universal Cell Therapy Drug Production Value Market Share by Type in 2022
Figure 34. Cell Therapy
Figure 35. Gene Therapy
Figure 36. Stem Cell Therapy
Figure 37. World Universal Cell Therapy Drug Production Market Share by Type (2018-2029)
Figure 38. World Universal Cell Therapy Drug Production Value Market Share by Type (2018-2029)
Figure 39. World Universal Cell Therapy Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Universal Cell Therapy Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Universal Cell Therapy Drug Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Research Center
Figure 44. World Universal Cell Therapy Drug Production Market Share by Application (2018-2029)
Figure 45. World Universal Cell Therapy Drug Production Value Market Share by Application (2018-2029)
Figure 46. World Universal Cell Therapy Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Universal Cell Therapy Drug Industry Chain
Figure 48. Universal Cell Therapy Drug Procurement Model
Figure 49. Universal Cell Therapy Drug Sales Model
Figure 50. Universal Cell Therapy Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World Universal Cell Therapy Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Universal Cell Therapy Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Universal Cell Therapy Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Universal Cell Therapy Drug Production Value Market Share by Region (2018-2023)
Table 5. World Universal Cell Therapy Drug Production Value Market Share by Region (2024-2029)
Table 6. World Universal Cell Therapy Drug Production by Region (2018-2023) & (K Units)
Table 7. World Universal Cell Therapy Drug Production by Region (2024-2029) & (K Units)
Table 8. World Universal Cell Therapy Drug Production Market Share by Region (2018-2023)
Table 9. World Universal Cell Therapy Drug Production Market Share by Region (2024-2029)
Table 10. World Universal Cell Therapy Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Universal Cell Therapy Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Universal Cell Therapy Drug Major Market Trends
Table 13. World Universal Cell Therapy Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Universal Cell Therapy Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Universal Cell Therapy Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Universal Cell Therapy Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Universal Cell Therapy Drug Producers in 2022
Table 18. World Universal Cell Therapy Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Universal Cell Therapy Drug Producers in 2022
Table 20. World Universal Cell Therapy Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Universal Cell Therapy Drug Company Evaluation Quadrant
Table 22. World Universal Cell Therapy Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Universal Cell Therapy Drug Production Site of Key Manufacturer
Table 24. Universal Cell Therapy Drug Market: Company Product Type Footprint
Table 25. Universal Cell Therapy Drug Market: Company Product Application Footprint
Table 26. Universal Cell Therapy Drug Competitive Factors
Table 27. Universal Cell Therapy Drug New Entrant and Capacity Expansion Plans
Table 28. Universal Cell Therapy Drug Mergers & Acquisitions Activity
Table 29. United States VS China Universal Cell Therapy Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Universal Cell Therapy Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Universal Cell Therapy Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Universal Cell Therapy Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Universal Cell Therapy Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Universal Cell Therapy Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Universal Cell Therapy Drug Production Market Share (2018-2023)
Table 37. China Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Universal Cell Therapy Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Universal Cell Therapy Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Universal Cell Therapy Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Universal Cell Therapy Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Universal Cell Therapy Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Universal Cell Therapy Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Universal Cell Therapy Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Universal Cell Therapy Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Universal Cell Therapy Drug Production Market Share (2018-2023)
Table 47. World Universal Cell Therapy Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Universal Cell Therapy Drug Production by Type (2018-2023) & (K Units)
Table 49. World Universal Cell Therapy Drug Production by Type (2024-2029) & (K Units)
Table 50. World Universal Cell Therapy Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Universal Cell Therapy Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Universal Cell Therapy Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Universal Cell Therapy Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Universal Cell Therapy Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Universal Cell Therapy Drug Production by Application (2018-2023) & (K Units)
Table 56. World Universal Cell Therapy Drug Production by Application (2024-2029) & (K Units)
Table 57. World Universal Cell Therapy Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Universal Cell Therapy Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Universal Cell Therapy Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Universal Cell Therapy Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Novartis Basic Information, Manufacturing Base and Competitors
Table 62. Novartis Major Business
Table 63. Novartis Universal Cell Therapy Drug Product and Services
Table 64. Novartis Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Novartis Recent Developments/Updates
Table 66. Novartis Competitive Strengths & Weaknesses
Table 67. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 68. Gilead Sciences Major Business
Table 69. Gilead Sciences Universal Cell Therapy Drug Product and Services
Table 70. Gilead Sciences Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Gilead Sciences Recent Developments/Updates
Table 72. Gilead Sciences Competitive Strengths & Weaknesses
Table 73. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 74. Bluebird Bio Major Business
Table 75. Bluebird Bio Universal Cell Therapy Drug Product and Services
Table 76. Bluebird Bio Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bluebird Bio Recent Developments/Updates
Table 78. Bluebird Bio Competitive Strengths & Weaknesses
Table 79. Juno Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. Juno Therapeutics Major Business
Table 81. Juno Therapeutics Universal Cell Therapy Drug Product and Services
Table 82. Juno Therapeutics Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Juno Therapeutics Recent Developments/Updates
Table 84. Juno Therapeutics Competitive Strengths & Weaknesses
Table 85. Spark Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Spark Therapeutics Major Business
Table 87. Spark Therapeutics Universal Cell Therapy Drug Product and Services
Table 88. Spark Therapeutics Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Spark Therapeutics Recent Developments/Updates
Table 90. Spark Therapeutics Competitive Strengths & Weaknesses
Table 91. Kite Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Kite Pharma Major Business
Table 93. Kite Pharma Universal Cell Therapy Drug Product and Services
Table 94. Kite Pharma Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Kite Pharma Recent Developments/Updates
Table 96. Kite Pharma Competitive Strengths & Weaknesses
Table 97. Celgene Basic Information, Manufacturing Base and Competitors
Table 98. Celgene Major Business
Table 99. Celgene Universal Cell Therapy Drug Product and Services
Table 100. Celgene Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Celgene Recent Developments/Updates
Table 102. Celgene Competitive Strengths & Weaknesses
Table 103. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Regeneron Pharmaceuticals Major Business
Table 105. Regeneron Pharmaceuticals Universal Cell Therapy Drug Product and Services
Table 106. Regeneron Pharmaceuticals Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Regeneron Pharmaceuticals Recent Developments/Updates
Table 108. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Adaptimmune Basic Information, Manufacturing Base and Competitors
Table 110. Adaptimmune Major Business
Table 111. Adaptimmune Universal Cell Therapy Drug Product and Services
Table 112. Adaptimmune Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Adaptimmune Recent Developments/Updates
Table 114. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 115. CRISPR Therapeutics Major Business
Table 116. CRISPR Therapeutics Universal Cell Therapy Drug Product and Services
Table 117. CRISPR Therapeutics Universal Cell Therapy Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Universal Cell Therapy Drug Upstream (Raw Materials)
Table 119. Universal Cell Therapy Drug Typical Customers
Table 120. Universal Cell Therapy Drug Typical Distributors
LIST OF FIGURE
Figure 1. Universal Cell Therapy Drug Picture
Figure 2. World Universal Cell Therapy Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Universal Cell Therapy Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Universal Cell Therapy Drug Production (2018-2029) & (K Units)
Figure 5. World Universal Cell Therapy Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Universal Cell Therapy Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Universal Cell Therapy Drug Production Market Share by Region (2018-2029)
Figure 8. North America Universal Cell Therapy Drug Production (2018-2029) & (K Units)
Figure 9. Europe Universal Cell Therapy Drug Production (2018-2029) & (K Units)
Figure 10. China Universal Cell Therapy Drug Production (2018-2029) & (K Units)
Figure 11. Japan Universal Cell Therapy Drug Production (2018-2029) & (K Units)
Figure 12. Universal Cell Therapy Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 15. World Universal Cell Therapy Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 17. China Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 22. India Universal Cell Therapy Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Universal Cell Therapy Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Universal Cell Therapy Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Universal Cell Therapy Drug Markets in 2022
Figure 26. United States VS China: Universal Cell Therapy Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Universal Cell Therapy Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Universal Cell Therapy Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Universal Cell Therapy Drug Production Market Share 2022
Figure 30. China Based Manufacturers Universal Cell Therapy Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Universal Cell Therapy Drug Production Market Share 2022
Figure 32. World Universal Cell Therapy Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Universal Cell Therapy Drug Production Value Market Share by Type in 2022
Figure 34. Cell Therapy
Figure 35. Gene Therapy
Figure 36. Stem Cell Therapy
Figure 37. World Universal Cell Therapy Drug Production Market Share by Type (2018-2029)
Figure 38. World Universal Cell Therapy Drug Production Value Market Share by Type (2018-2029)
Figure 39. World Universal Cell Therapy Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Universal Cell Therapy Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Universal Cell Therapy Drug Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Research Center
Figure 44. World Universal Cell Therapy Drug Production Market Share by Application (2018-2029)
Figure 45. World Universal Cell Therapy Drug Production Value Market Share by Application (2018-2029)
Figure 46. World Universal Cell Therapy Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Universal Cell Therapy Drug Industry Chain
Figure 48. Universal Cell Therapy Drug Procurement Model
Figure 49. Universal Cell Therapy Drug Sales Model
Figure 50. Universal Cell Therapy Drug Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
